Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe 2.4mg dose of Wegovy — the maintenance strength of once-weekly semaglutide — is a prescription-only medicine, and UK private prices vary considerably depending on who supplies it and what that price actually covers. Typical private costs at the 2.4mg level sit in a broad range, and the headline figure you see advertised rarely tells the whole story. As a prescription-only medicine, Wegovy can only be legally supplied following a clinical assessment by a qualified prescriber; the dose you start on and how quickly you reach 2.4mg is a decision made with your clinical team, not one you make at checkout. Our Wegovy overview covers the full treatment in detail.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The biggest misconception around Wegovy pricing is that the figure on a website represents the total cost of treatment. It rarely does. Private providers structure their fees differently, and what looks like a straightforward monthly price can quietly exclude a consultation fee, a separate prescription charge, delivery, and any dose-review support along the way. When you add those up, the actual spend each month often looks quite different from the number that first caught your eye.
To give you useful context: Eli Lilly's UK list price for Mounjaro rose sharply from 1 September 2025, and Novo Nordisk's pricing sits in a similar market. Across private providers in the UK, the 2.4mg Wegovy maintenance dose typically attracts prices somewhere in the range of £149 to £375 per month, depending on the provider and what is bundled in, figures that have been widely reported since mid-2025. That range reflects genuine market variation, not a standard. Our Wegovy pricing page sets out what to expect in more detail.
The other thing worth knowing: 2.4mg is the standard maintenance dose, not where treatment begins. Wegovy starts at 0.25mg and is titrated upward over several months by the prescriber. You reach 2.4mg only when your prescriber confirms it is clinically appropriate. If you want to see how the maintenance dose is priced specifically, our page covering Wegovy 2.4mg prices breaks down what providers are currently charging. The cost you pay at 2.4mg is therefore the cost after a period of lower-dose treatment, that earlier phase matters too when you are thinking about total outlay.
It is worth being specific about what can fall outside a headline Wegovy price, because the gaps matter. Some providers charge separately for the initial consultation (occasionally £30 to £60 or more) as a prerequisite to ordering. Others include the consultation but not the prescription fee, or include both but add a delivery charge. Aftercare is perhaps the most variable element: ongoing clinical support, dose-review checks, and access to a prescriber when you have a question mid-treatment can be included, charged per contact, or absent entirely.
None of this is unique to Wegovy. It is a pattern across private prescribing in the UK for prescription medicines generally. The practical implication is straightforward: before you compare two prices, ask what each one actually covers from consultation to delivery to repeat support. A closer look at Wegovy 2.4mg costs works through those components in more detail.
Prescription medicines also need proper clinical oversight at every stage. A lower price for Wegovy may reflect a thinner clinical layer, not genuine efficiency. That distinction is worth keeping in mind.
nume's position is straightforward and we say it plainly: price is not the race we entered. One price covers everything, your consultation, your prescription, your treatment, and free next-working-day tracked delivery via DPD. Your pen arrives in plain, unbranded packaging; you will get a DPD tracking notification so you know exactly when it is coming. There are no subscription commitments and no auto-renewals; every repeat order goes back to a prescriber for clinical re-review before anything is sent.
The clinical layer is not a checkbox. A named GPhC-registered Independent Prescriber reads your consultation personally, the same day. Photo ID is verified, weight is confirmed on video, and dose increases require clinical evidence, the kind of infrastructure that keeps treatment safe, not just convenient. You can verify our pharmacy on the GPhC register (registration 9012878) any time. That is our strongest trust signal and we think it should be.
If you want to explore how our pricing compares across dose levels, the Wegovy 2.4mg price page has the current figures. Our clinical team is described in full on the prescriber profile page if you would like to know who reviews your case.
A small saving on a prescription medicine is not the metric that keeps you safe. Wegovy is not a supplement or a cosmetic product. It is a Prescription-Only Medicine that requires genuine clinical assessment, a legitimate supply chain, and proper ongoing oversight. The MHRA has warned publicly about counterfeit weight-loss pens sold online and via social media; enforcement operations in 2025 seized roughly 20 million doses of illegally traded weight-loss medicines at an estimated street value of around £45 million, including a UK site producing fake tirzepatide pens. Fake pens have been found to contain insulin. This is not a theoretical risk.
The practical test for any provider is simple: can you verify them on the GPhC pharmacy register? Are you receiving a clinical consultation with a qualified prescriber? Is the medicine coming through a licensed UK supply chain? If a seller is offering Wegovy without a prescription, at a price far below anything else in the market, or through a social media post, those are red flags the MHRA has specifically identified.
For a prescription medicine, the question that actually protects you is not which provider charges the least, it is which provider offers genuine clinical oversight and a legitimate supply. You can start a free consultation with our prescribers to find out whether Wegovy is suitable for you, with no obligation and no upfront fee to do so. The FAQs cover common questions if you want to read further before starting.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.